FDA Waxman/Hatch Policy Change Afforded Full White House Honors

The White House Waxman/Hatch reform proposal reflects the policy development approach of FDA Chief Counsel Daniel Troy - and the Administration-insider status of incoming Commissioner Mark McClellan